Home Cart Sign in  
Chemical Structure| 947669-91-2 Chemical Structure| 947669-91-2

Structure of WWL70
CAS No.: 947669-91-2

Chemical Structure| 947669-91-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

WWL70 is a selective inhibitor of the alpha/beta hydrolase domain 6 (ABHD6), exhibiting an IC50 of 70 nM.

Synonyms: WWL70

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of WWL70

CAS No. :947669-91-2
Formula : C27H23N3O3
M.W : 437.49
SMILES Code : O=C(OC1=CC=C(C2=CC=C(C(N)=O)C=C2)C=C1)N(C)CC3=CC=CC(C4=CC=NC=C4)=C3
Synonyms :
WWL70
MDL No. :MFCD10567112

Safety of WWL70

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Acute accumbal slices 1 µM 10 minutes WWL70 mimicked the anti-insulin action of dexamethasone, supporting the involvement of 2-AG in the glucocorticoid-induced insulin resistance Brain Res Bull. 2016 Jun;124:222-30
Primary microglia cells 10 µM 30 min Suppressed PGE2 production in LPS-activated microglia J Neuroinflammation. 2017 Jan 10;14(1):7
BV2 cells 10 µM 30 min Inhibited 2-AG hydrolysis and elevated intracellular 2-AG levels J Neuroinflammation. 2017 Jan 10;14(1):7
Primary peritoneal macrophages 10 µM 8 hours To confirm the effect of ABHD6 inhibition in primary peritoneal macrophages, WWL70 significantly increased 2-AG levels and reduced LPS-induced IL-1β mRNA expression Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17558-63
BV2 microglial cells 10 µM 8 hours To confirm the effect of ABHD6 inhibition in BV2 cells, WWL70 significantly increased 2-AG levels and reduced LPS-induced IL-1β mRNA expression Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17558-63
RAW264.7 macrophages 10 µM 8 hours To confirm the effect of ABHD6 inhibition in RAW264.7 cells, WWL70 significantly increased 2-AG levels and reduced LPS-induced IL-1β mRNA expression Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17558-63
J774 macrophages 0.3 µM (EC50) 8 hours To assess the implication of ABHD6 in 2-AG metabolism by macrophages, WWL70 dose-dependently increased 2-AG levels and reduced LPS-induced IL-1β mRNA expression Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17558-63

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Experimental autoimmune encephalomyelitis (EAE) Intraperitoneal injection 10 mg/kg Once daily until the end of experiment Alleviated clinical symptoms and reduced PGE2 production in brain tissues of EAE mice J Neuroinflammation. 2017 Jan 10;14(1):7
C57BL/6J mice Chronic constriction injury (CCI) model of sciatic nerve Intraperitoneal injection 10 mg/kg Starting 3 hours post-surgery, once daily for 7 days WWL70 significantly alleviated CCI-induced thermal hyperalgesia and mechanical allodynia, reduced microglia activation, macrophage infiltration, and the production of nociceptive mediators in the ipsilateral lumbar spinal cord dorsal horn, DRG, and sciatic nerve. J Neuroinflammation. 2018 Jan 8;15(1):9
Mice LPS-induced inflammation model Intraperitoneal injection 20 mg/kg Single administration, assessed after 4 hours To assess the anti-inflammatory effects of ABHD6 inhibition in vivo, WWL70 significantly reduced LPS-induced proinflammatory cytokine expression without increasing brain 2-AG levels Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17558-63
C57BL/6 mice Traumatic brain injury (TBI) model Intraperitoneal injection 5 mg/kg or 10 mg/kg Once daily for 3, 7, or 21 days WWL70 treatment improved motor coordination and working memory performance, reduced lesion volume in the cortex and neurodegeneration in the dentate gyrus, suppressed the expression of inducible nitric oxide synthase and cyclooxygenase-2, and enhanced the expression of arginase-1 in the ipsilateral cortex at 3 and 7 days post-TBI, suggesting microglia/macrophages shifted from M1 to M2 phenotypes after treatment. The blood-brain barrier dysfunction at 3 and 7 days post-TBI was dramatically reduced. J Neurotrauma. 2013 Apr 1;30(7):565-79

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.29mL

0.46mL

0.23mL

11.43mL

2.29mL

1.14mL

22.86mL

4.57mL

2.29mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories